
1. Why is PHN in the head and face so difficult to treat?
The difficulty in treating postherpetic neuralgia (PHN) of the head and face stems primarily from the unique pathophysiology of this condition.
First, the head and face are innervated by an exceptionally dense and intricate network of nerves. Major nerves—including the trigeminal, facial, and occipital nerves—converge in this region. Once damaged, the pain signalling pathways become highly complex and widespread.
Second, PHN is fundamentally neuropathic pain—it is not tissue inflammation but rather a malfunction of the nervous system itself. Conventional analgesics often provide only temporary symptom relief and rarely address the underlying cause.
Third, the skin of the head and face is thin, richly vascularised, and packed with nerve endings. External treatments demand a high degree of precision, placing stringent requirements on the safety and controllability of any therapy.
2. Viral "residue"—an often‑overlooked key factor
Why does pain persist for months or even years in some patients? One crucial factor is viral residue.
After the acute phase of shingles, if treatment is delayed or inadequate, some virus particles may remain in the deep layers of the skin, continuously irritating nerve endings. This persistent irritation acts like a "thorn" embedded in the nerve—unless the thorn is removed, pain relief can only be temporary.
In a sense, trigeminal neuralgia can also be understood as a form of "zoster sine herpete" (shingles without a rash)—the virus erupts in the trigeminal region of the head and face but produces no obvious blisters, or the blisters are overlooked, ultimately manifesting as severe facial neuralgia.
1. What does "Five‑linked" mean? – A multi‑pronged therapeutic rationale
The Five‑linked Anti‑drug Pain Therapy is a comprehensive external treatment modality in traditional Chinese medicine. Its core philosophy can be summarised by two key actions: "drawing out toxins" and "relieving pain."
"Drawing out toxins" refers to the professional removal of viral toxins that remain lodged in the deep skin layers and continuously stimulate nerves. "Relieving pain" means that, once the cause is cleared, the nerves can repair themselves and pain subsides.
The therapy employs a specially formulated medicinal solution and herbal agents, which are mixed and applied as a topical dressing. Each session lasts approximately ten to fifteen minutes and is typically performed once daily. The entire procedure is carried out by qualified medical personnel in a licensed healthcare facility.
2. Precise targeting: from "blind pain relief" to "targeted toxin extraction"
A notable feature of the Five‑linked Anti‑drug Pain Therapy is its emphasis on precise localisation.
Before treatment begins, dedicated imaging equipment is used to scan the head and face to identify the exact location and extent of nerve irritation caused by the virus. This step is vital—given the complex anatomy and dense innervation of the head and face, accurate positioning ensures that the intervention is directed precisely where it is needed.
Once the target area is identified, the therapy is applied directly to the painful or abnormal‑sensation zone. The medicated solution and formulated agents rapidly penetrate the tissue, neutralising and dissolving the toxins that provoke nerve pain. Many patients report immediate or noticeable relief in pain or abnormal sensations after the session.
3. Step‑by‑step progression: from the "main battlefield" to "clearing the field"
The treatment process follows a principle of "moving from major to minor areas, layer by layer."
The first session typically focuses on the "main battlefield"—the area of most intense pain. Later on the same day or the following evening, patients may experience pain or itching in surrounding regions. This is not a worsening of the condition but rather a normal response indicating that deep‑seated toxins are being activated and expelled outward.
On subsequent days, treatment is extended to adjacent areas, and so on. This "layered advancement" ensures comprehensive and thorough coverage, avoiding superficial results that fail to address the root cause.
1. Indications
The Five‑linked Anti‑drug Pain Therapy is primarily indicated for:
Postherpetic neuralgia (including head‑and‑face PHN)
Postherpetic neuralgia without rash (zoster sine herpete)
Trigeminal neuralgia
Unexplained cutaneous neuralgia and abnormal sensations
However, it is important to note that therapeutic outcomes are closely related to individual patient conditions.
2. Key prerequisite: absence of serious underlying diseases
Based on clinical experience, the therapy is more effective in patients without serious underlying conditions. For individuals with significant comorbidities such as diabetes, bone diseases, post‑cancer surgery, leukaemia, liver cirrhosis, or unstable conditions following liver/kidney/lung transplantation, a greater number of treatment sessions may be required.
The therapy is not applicable to patients with internal lesions such as intraocular ulceration, intestinal involvement, or intracranial manifestations.
3. Strict adherence to contraindications – the "other half" of recovery
Within the therapeutic framework, observance of contraindications is given paramount importance.
During the treatment period and for a certain time after recovery, patients and their families must strictly comply with the prescribed contraindication instructions—especially dietary restrictions. Failure to adhere to dietary guidelines may not only prolong the number of sessions needed but also compromise the final outcome.
This is not an undue burden on patients but is based on a straightforward medical rationale: the therapy works to "clear" viral toxins, while the contraindications prevent new "irritants" from entering the body and interfering with the nerve repair process.
Based on extensive clinical experience, for patients without serious underlying diseases who strictly observe the contraindication instructions:
For acute‑phase shingles within one week of onset, before extensive ulceration of blisters: most patients experience gradual symptom resolution within 1 to 3 sessions.
For head‑and‑face PHN and trigeminal neuralgia: most patients show improvement or gradual pain elimination within 3 to 8 sessions.
A small proportion of patients may require more than ten sessions.
In very rare cases with severe disease, additional sessions may still lead to improvement or symptom resolution.
It must be emphasised that treatment outcomes vary from person to person and are influenced by multiple factors, including individual differences, disease duration, underlying health conditions, and compliance with contraindication guidelines.
Disclaimer:
This content is a summary of clinical experience and observations from TianDao Traditional Chinese Medicine over many years. It is intended for patient education, public awareness, and scientific exchange. It does not constitute a guarantee of cure, safety, or efficacy for any condition, nor is it a promotional promise.